Cram is not yet available for this lesson.
Guest access stays fully free. Create a free account to keep module completion and study preferences synced on every device. No paid subscription is required for Pre-Nursing.
Pre-Nursing stays free. Progress is optional.
Start your first module to build momentum and unlock personalized recommendations.
Suggested next in sequence: medical-terminology
Paid NurseNest plans add full question banks, mocks, and pathway-scoped lessons once you are comfortable with the basics here.
Set a likely route on the study planning page to personalize these links.
Focus on foundations here; we’ll keep exam prep one click away.
A college-preparatory survey of disease mechanisms — from cellular injury and inflammation through organ-system failure. Every mechanism is explained, not just named, so you can predict clinical findings, understand why treatments work, and recognize deterioration before it becomes catastrophic.
Visual learning
See disease as a sequence from risk factor to cell stress, compensation, decompensation, and complication.
Risk factor
A vulnerability increases the chance of injury or disease.
Trigger or insult
Infection, hypoxia, trauma, toxin, genetics, or inflammation starts the process.
Cell stress
Cells lose oxygen, energy, membrane integrity, or normal signaling.
Compensation
The body adapts through heart rate, breathing, hormones, or fluid shifts.
Decompensation
Compensation fails and safety-priority findings appear.
Complication
Organ dysfunction, shock, sepsis, arrhythmia, or neurologic change can follow.
Clinical connection
This map helps learners explain why early cues matter before the patient looks obviously unstable.
The molecular basis of tissue damage
Every disease process begins at the cellular level. Understanding how cells are injured, how they adapt, and when they die irreversibly gives you the framework to interpret every lab value, every symptom, and every treatment decision in clinical practice.
Ischemia denatures structural proteins while preserving the tissue architecture as a 'ghost outline.' The cell outline is visible under microscopy for days. Seen in: myocardial infarction (MI), renal infarction, splenic infarction. The preserved scaffold is why troponin, CK-MB, and myoglobin are released gradually — as the membrane breaks down over hours, biomarkers leak into the bloodstream. Clinical pearl: a patient with chest pain for 2 hours may have initial troponin negative — repeat at 3–6 hours for the troponin rise.
Hydrolytic enzymes digest the dead tissue into a liquid, creamy material. Seen in: (1) Brain infarction — neurons are rich in lipids and hydrolytic enzymes; after ischemic stroke, the infarcted area liquefies over weeks into a fluid-filled cavity (encephalomalacia). (2) Bacterial infections — neutrophils pour into infected tissue, release hydrolytic enzymes, and digest both bacteria and host tissue → abscess formation (pocket of pus = liquefactive necrosis + living and dead neutrophils + bacteria).
A combination of coagulative and liquefactive necrosis producing a soft, white, cheese-like (caseous) material. Unique to granulomatous infections, especially Mycobacterium tuberculosis. The granuloma structure: caseous center surrounded by epithelioid macrophages (fused into Langhans giant cells) surrounded by lymphocytes. The bacteria survive inside macrophages by blocking phagolysosome fusion. Caseous necrosis with cavitation in the upper lung lobes on CXR is the classic TB presentation. The Mantoux/TST skin test and IGRA (QuantiFERON) detect Type IV hypersensitivity to TB antigens.
Fat necrosis occurs when pancreatic lipases leak into peripancreatic fat (acute pancreatitis) or when fat cells are traumatized (breast). Lipases break down triglycerides into fatty acids, which bind calcium salts → calcium soaps (saponification) → chalky white deposits visible on CT/MRI. Clinically: acute pancreatitis causes serum calcium to drop (hypocalcemia) as calcium is sequestered in fat necrosis plaques — check Ca²⁺ in all pancreatitis patients. Serum Ca²⁺ <8 mg/dL in pancreatitis is a Ranson's severity criterion.
Why the Brain Dies in 4–6 Min but the Heart in 20–40 Min
Ischemic injury is the most clinically important type. When blood flow stops, oxygen delivery stops. Oxidative phosphorylation halts within seconds. ATP stores are exhausted within minutes. Without ATP, the Na⁺/K⁺-ATPase pump stops — the pump that normally extrudes 3 Na⁺ out and brings 2 K⁺ in with every ATP consumed. Na⁺ floods in, water follows osmotically, and the cell swells. Ca²⁺ pumps also fail, flooding the cell with calcium that activates destructive phospholipases, proteases, and endonucleases. The brain exhausts its ATP in 4–6 minutes; the heart in 20–40 minutes (myoglobin stores a small O₂ reserve). This is why time to reperfusion is the single most critical determinant of outcome in stroke and MI.
Apoptosis vs Necrosis: The Mechanisms That Drive Clinical Decisions
Apoptosis is elegant cell death — the cell packages itself for disposal without triggering inflammation. In the intrinsic pathway, cellular stress (DNA damage, oxidative stress, hypoxia) causes mitochondria to release cytochrome c into the cytoplasm. Cytochrome c binds Apaf-1 to form the apoptosome, which activates caspase-9, which activates downstream executioner caspases (caspase-3, -6, -7). These proteases dismantle the cell from within: DNA is cleaved into nucleosomal fragments (giving the 'DNA ladder' on gel electrophoresis), the nucleus condenses, and the cell blebs into membrane-bound apoptotic bodies. Macrophages phagocytose these bodies without releasing inflammatory mediators. Nurses observe apoptosis clinically: chemotherapy agents kill cancer cells by triggering apoptosis; radiation does the same. When apoptosis fails (e.g., BCL-2 overexpression in follicular lymphoma), cancer cells become immortal.
Nursing Assessment Priority: Recognizing Cell Death Clinically
Cell death manifests as organ dysfunction and biomarker elevation. The nurse's role is to recognize these patterns: Cardiac necrosis → troponin rise + ST changes + chest pain + diaphoresis. Hepatocyte necrosis → AST/ALT elevation + jaundice + coagulopathy (liver makes clotting factors). Muscle necrosis (rhabdomyolysis) → CK elevation (often >10,000 U/L) + myoglobinuria (dark 'tea-colored' urine) + AKI risk (myoglobin precipitates in tubules). Pancreatic necrosis → lipase/amylase elevation + periumbilical and flank ecchymosis (Cullen's and Grey Turner's signs in hemorrhagic pancreatitis). Monitor for SIRS in any patient with large-scale necrosis — cellular contents spilling into the bloodstream can trigger systemic inflammatory response.
A patient has an MI. After 30 minutes of coronary occlusion, the affected cardiomyocytes undergo coagulative necrosis. Which mechanism BEST explains why cell death becomes irreversible?
The body's first responder: powerful, necessary, and sometimes destructive
Inflammation is not the enemy — it is a precisely orchestrated defense response designed to eliminate threats and initiate healing. The same mechanism that clears bacteria also causes the heat, pain, and swelling of a sprained ankle. Understanding it mechanistically lets you predict why anti-inflammatory drugs work, why chronic inflammation causes tissue damage, and why some infections go poorly.
Vascular Phase (Immediate)
Within seconds of injury: transient vasoconstriction → sustained vasodilation (histamine, prostaglandins) → increased blood flow to area (rubor — redness, calor — heat). Vascular permeability increases (histamine, bradykinin, C3a, C5a, leukotrienes) → protein-rich fluid leaks into interstitium (tumor — swelling, exudate formation). Plasma proteins including antibodies, complement, and fibrinogen now gain access to the injury site.
Cellular Phase (Hours)
Neutrophils (first responders — arrive within 6–24 hours) migrate from blood to tissue: (1) Margination — neutrophils roll along endothelium via selectins. (2) Adhesion — ICAM/integrin binding. (3) Diapedesis — neutrophils squeeze between endothelial cells. (4) Chemotaxis — migrate toward chemical gradients (C5a, IL-8, leukotriene B4). (5) Phagocytosis — engulf opsonized pathogens. (6) Killing — respiratory burst (NADPH oxidase → superoxide) + lysosomal enzymes.
Stored preformed in mast cell granules, released within seconds of injury or allergen exposure. Actions: H1 receptors → vasodilation, increased vascular permeability, bronchospasm, pruritus. H2 receptors → gastric acid secretion. Drug targets: H1 antihistamines (diphenhydramine, loratadine) block H1 receptors → reduce allergy symptoms, urticaria, anaphylaxis itching/wheals. H2 blockers (famotidine, ranitidine) reduce gastric acid. Key point: antihistamines do NOT reverse anaphylactic shock — only epinephrine does that.
Arachidonic acid is converted by COX-1/COX-2 to prostaglandins. PGE₂ and PGI₂ sensitize pain receptors (hyperalgesia — dolor), cause vasodilation (rubor/calor), and act on the hypothalamic thermostat to raise set point (fever). Thromboxane A₂ (from COX-1 in platelets) promotes platelet aggregation and vasoconstriction. NSAIDs block COX → ↓prostaglandins → reduced pain, fever, inflammation. Aspirin irreversibly acetylates COX (7–10 day antiplatelet effect). Selective COX-2 inhibitors (celecoxib) spare COX-1 (GI protection, platelet function) but increase thrombotic risk.
Arachidonic acid is also metabolized by 5-lipoxygenase (5-LOX) → leukotrienes. LTB₄ is a potent neutrophil chemoattractant. LTC₄, LTD₄, LTE₄ (the cysteinyl leukotrienes) cause bronchospasm (more potent than histamine), increased vascular permeability, and mucus secretion. This is why they are critical in asthma pathophysiology. Drug target: montelukast (Singulair) and zafirlukast block leukotriene receptors → used in mild persistent asthma and allergic rhinitis. Note: aspirin-exacerbated respiratory disease (aspirin-sensitive asthma) occurs because blocking COX shunts arachidonic acid to the LOX pathway → excess leukotrienes → severe bronchospasm.
Complement is a cascade of plasma proteins activated by three pathways (classical — antibody-antigen, lectin — mannose binding, alternative — direct pathogen surface activation). Key products: C3b — opsonin (coats bacteria for phagocytosis). C3a and C5a — anaphylatoxins (mast cell degranulation, vasodilation, neutrophil chemotaxis). C5b-9 — membrane attack complex (MAC) directly lyses gram-negative bacteria by punching holes in their membranes. Clinical relevance: C5a is elevated in sepsis and contributes to the cytokine storm. Hereditary C1 inhibitor deficiency → hereditary angioedema (bradykinin-mediated — does NOT respond to epinephrine or antihistamines; treat with C1 esterase inhibitor concentrate or icatibant).
Macrophages release IL-1, IL-6, and TNF-α (the 'big three' pro-inflammatory cytokines) in response to infection and injury. Systemic effects: fever (IL-1, IL-6, TNF-α act on hypothalamus via PGE₂), acute-phase protein synthesis in liver (C-reactive protein, fibrinogen, ferritin — CRP rises within hours, useful inflammatory marker), neutrophilia (IL-6 stimulates bone marrow → shift to immature neutrophils = left shift). TNF-α is also the key mediator of septic shock (massive vasodilation, myocardial depression). Drug targets: biologics block specific cytokines — infliximab/adalimumab (anti-TNF), tocilizumab (anti-IL-6 receptor — used in RA, cytokine release syndrome), anakinra (anti-IL-1).
Why NSAIDs Reduce All 5 Cardinal Signs of Inflammation
NSAIDs (ibuprofen, naproxen, aspirin, ketorolac) work by blocking cyclooxygenase enzymes (COX-1 and COX-2), which convert arachidonic acid to prostaglandins and thromboxanes. Prostaglandins sensitize pain receptors (dolor), cause vasodilation (rubor and calor), and act on the hypothalamus to raise the set point (fever). By blocking prostaglandin synthesis, NSAIDs reduce all five cardinal signs of inflammation — pain, heat, redness, swelling (by reducing vasodilation and permeability), and loss of function. The distinction between COX-1 (constitutive — protects gastric mucosa, maintains platelet aggregation) and COX-2 (inducible by inflammation) explains why non-selective NSAIDs cause GI bleeding: they block protective COX-1. Selective COX-2 inhibitors (celecoxib) spare the GI tract but increase cardiovascular thrombotic risk because they still inhibit prostacyclin (anti-thrombotic) without inhibiting thromboxane A₂ (pro-thrombotic).
Nursing Assessment Priority: Reading the Inflammatory Response
Inflammation produces measurable signs the nurse must interpret — not just document. Temperature: fever (>38°C/100.4°F) indicates systemic cytokine activation — note the PATTERN (continuous = bacterial, quotidian = certain infections, remittent = most common). Hypothermia (<36°C) in sepsis = more alarming than fever (indicates overwhelming sepsis with failed thermoregulatory response). WBC with differential: leukocytosis (>11,000) with left shift (>10% bands/immature neutrophils) = active bacterial infection or physiological stress. Leukopenia (<4,000) in sepsis = very high mortality risk. CRP and ESR: non-specific markers of inflammation — CRP rises within 6 hours, ESR within 24–48 hours. Used to trend inflammatory response to treatment. Local signs: rubor, tumor, calor, dolor, functio laesa at a wound site are normal and healthy — they indicate the immune system is working. Absence of local inflammation in an immunocompromised patient (neutropenic — ANC <500) means you cannot rely on these signs; they may have severe infection with minimal findings.
When body fluid distribution goes wrong
Fluid and electrolyte imbalances are among the most common clinical problems in any healthcare setting. Every shift, nurses encounter patients with edema, dehydration, abnormal electrolytes, and third-spacing. Understanding the underlying mechanisms — not just the normal ranges — allows you to anticipate complications and prioritize interventions.
Normal capillary hydrostatic pressure (~32 mmHg at arteriolar end, ~15 mmHg at venous end) drives fluid out. When venous pressure backs up — due to right heart failure, portal hypertension (cirrhosis), or venous obstruction (DVT) — the venous end pressure rises, net filtration increases, and fluid accumulates in the interstitium. Right heart failure → bilateral lower extremity pitting edema, hepatomegaly, ascites. Left heart failure → pulmonary edema (increased pulmonary capillary wedge pressure). Treatment: diuretics (furosemide reduces preload by inhibiting Na-K-2Cl cotransporter in thick ascending limb), fluid restriction, treat underlying cause.
Albumin (normal 3.5–5.0 g/dL) generates ~80% of plasma oncotic pressure (~25 mmHg), which holds fluid in the vasculature. When albumin falls below 2.0–2.5 g/dL, oncotic pressure is insufficient to retain fluid → transudative edema. Causes: (1) Cirrhosis — decreased albumin synthesis. (2) Nephrotic syndrome — massive proteinuria (>3.5 g/day) loses albumin in urine. (3) Protein-calorie malnutrition (kwashiorkor) — insufficient albumin production. (4) Protein-losing enteropathy. Treatment: address the underlying cause. Giving IV albumin has limited benefit unless the underlying protein loss or synthesis failure is corrected. Diuretics alone can worsen intravascular depletion.
Normally, the capillary wall is selectively permeable — small molecules pass, but proteins (albumin) are retained in the vasculature. In severe inflammation, burns, or sepsis, mediators (histamine, bradykinin, IL-1, TNF-α, VEGF) widen intercellular gaps → proteins leak into the interstitium → increased interstitial oncotic pressure pulls water out of vessels. This is 'leaky capillary' edema. The fluid is protein-rich (exudate, specific gravity >1.020) unlike low-protein transudates from hydrostatic/oncotic causes. In burns patients: massive plasma loss into burned tissue → intravascular hypovolemia despite total body water being normal → requires aggressive fluid resuscitation (Parkland formula: 4 mL × %TBSA burn × weight in kg, half in first 8 hours, half in next 16).
The lymphatic system normally returns protein-rich interstitial fluid to the circulation. When lymphatics are obstructed (after axillary lymph node dissection for breast cancer, pelvic lymph node removal, or filariasis — Wuchereria bancrofti infection), protein accumulates in the interstitium → progressive, brawny (non-pitting), protein-rich edema. The limb becomes chronically swollen and fibrotic over time. Key distinction: lymphedema is NON-PITTING (firm, does not indent on pressure) in established disease because fibrosis has occurred. Does NOT respond to diuretics — must use elevation, compression garments, and manual lymphatic drainage (decongestive therapy).
Hypokalemia (<3.5 mEq/L)
Causes: Loop/thiazide diuretics (most common clinical cause — kidneys waste K⁺), vomiting (lose HCl → alkalosis → K⁺ shifts into cells + aldosterone → renal K⁺ loss), diarrhea (GI K⁺ loss), hyperaldosteronism, inadequate intake.
Manifestations: Muscle weakness (ascending — starts in legs → ileus → hypoventilation if severe), cardiac arrhythmias (U waves on ECG, prolonged QT, increased digoxin toxicity — K⁺ competes with digoxin at Na⁺/K⁺-ATPase).
Treatment: Oral KCl (preferred if GI tolerated). IV KCl maximum rate 10–20 mEq/hr through peripheral IV, 40 mEq/hr through central line with cardiac monitoring. Always replace Mg²⁺ first — hypomagnesemia causes refractory hypokalemia.
Hyperkalemia (>5.5 mEq/L)
Causes: AKI/CKD (kidneys can't excrete K⁺), ACE inhibitors and ARBs (block aldosterone → K⁺ retention), K⁺-sparing diuretics (spironolactone, amiloride), cell lysis (tumor lysis syndrome, rhabdomyolysis, hemolysis), acidosis (H⁺ shifts into cells, K⁺ shifts out — 0.6 mEq/L rise per 0.1 pH unit decrease).
Manifestations: Peaked T waves → widened QRS → sine wave pattern → VFib/asystole. Also: muscle weakness, paresthesias.
Treatment sequence: (1) Calcium gluconate IV — stabilizes cardiac membrane (minutes). (2) Insulin + dextrose — shifts K⁺ into cells (30 min). (3) Sodium bicarbonate if acidosis. (4) Albuterol nebulizer (shifts K⁺ in). (5) Kayexalate/patiromer/sodium zirconium — remove K⁺ from body.
Hyponatremia Correction: Slower Is Safer
Correcting hyponatremia too rapidly is more dangerous than the hyponatremia itself in chronic cases. When sodium has been low for more than 48 hours, brain cells adapt by extruding organic osmolytes (taurine, glutamate, myoinositol) to prevent cerebral edema. If you then rapidly raise serum sodium, the brain is now hypo-osmolar relative to the new plasma osmolality. Water rapidly exits brain cells → neurons shrink → the myelin sheaths of pontine neurons — already stressed — rupture. This is osmotic demyelination syndrome (ODS), also called central pontine myelinolysis. Symptoms appear 2–6 days after rapid correction: dysarthria, dysphagia, quadriparesis, locked-in syndrome. It is irreversible. The rule: correct no faster than 8–10 mEq/L per 24 hours. In chronic hyponatremia, the priority is slow, controlled correction — not speed.
Nursing Assessment Priority: Fluid Status Head-to-Toe
Every fluid assessment tells a hemodynamic story. Mucous membranes (dry = dehydrated), skin turgor (tenting = dehydration — less reliable in elderly), capillary refill (>2 sec = poor perfusion). Vital signs: tachycardia (earliest sign of hypovolemia), orthostatic hypotension (BP drops >20 mmHg systolic or >10 mmHg diastolic on standing — indicates at least 20% volume depletion). Neck veins: JVD at >45° = elevated venous pressure (fluid overload, right HF). Flat neck veins even supine = severe hypovolemia. Lung sounds: crackles = fluid in alveoli (pulmonary edema or pneumonia). Daily weight: the most accurate volume assessment available — 1 kg ≈ 1 liter. Peripheral edema: grade 1+ (2 mm, resolves rapidly) to 4+ (>8 mm, resolves in >20 sec). Note sacral edema in bedbound patients — dependent edema follows gravity.
Reading ABGs and understanding the body's pH defense systems
Acid-base disorders are among the most informative clinical data points available. A correctly interpreted ABG tells you not just what is wrong with the pH, but what organ system is failing, how long it has been failing, and whether compensation is occurring. Every nurse must be able to interpret a basic ABG.
Normal ABG Values and the ROME Framework
pH
7.35–7.45
PaCO₂
35–45 mmHg
HCO₃⁻
22–26 mEq/L
PaO₂
80–100 mmHg
ROME mnemonic: Respiratory Opposite (pH and PaCO₂ move in opposite directions in primary respiratory disorders — if CO₂ rises, pH falls). Metabolic Equal (pH and HCO₃⁻ move in the same direction in primary metabolic disorders — if HCO₃⁻ falls, pH falls). Step 1: Is pH acidotic or alkalotic? Step 2: Is CO₂ or HCO₃⁻ the primary abnormality (matches ROME)? Step 3: Is there compensation (the other value moving to normalize pH)?
Primary problem: CO₂ cannot be exhaled → accumulates → CO₂ + H₂O → H₂CO₃ → H⁺ + HCO₃⁻ → pH falls. Causes: COPD exacerbation, opioid/sedative overdose (respiratory center depression), neuromuscular disease (Guillain-Barré, ALS, myasthenia gravis crisis), obesity hypoventilation, tension pneumothorax, severe bronchospasm. Compensation: kidneys retain HCO₃⁻ and excrete H⁺ — takes 3–5 days for full compensation, so HCO₃ rises 3–4 mEq/L per 10 mmHg acute CO₂ rise. Nursing priorities: ensure airway patency, positioning (head of bed 30–45°), assess level of consciousness (rising CO₂ → narcosis → coma), prepare for BiPAP/intubation if worsening. If opioid OD: naloxone.
Primary problem: hyperventilation removes CO₂ faster than it is produced → PaCO₂ falls → H⁺ falls → pH rises. Causes: anxiety/panic attack, pain, pulmonary embolism (hypoxia and pain drive hyperventilation — respiratory alkalosis is the MOST COMMON ABG finding in PE), aspirin toxicity (early phase — salicylates directly stimulate the respiratory center; late phase shifts to metabolic acidosis), pregnancy (progesterone stimulates respiratory drive), fever, early sepsis (before lactic acidosis develops), high altitude. Symptoms: perioral tingling, carpal-pedal spasm (Trousseau's sign — alkalosis causes Ca²⁺ to bind more avidly to albumin → less ionized Ca²⁺ → tetany), lightheadedness, near-syncope. Compensation: kidneys excrete HCO₃⁻ (takes days). Nursing: address underlying cause, reassurance and coaching for anxiety-driven hyperventilation.
Primary problem: excess acid produced, ingested, or HCO₃⁻ lost → HCO₃⁻ falls → pH falls. Anion gap (AG) = Na⁺ − (Cl⁻ + HCO₃⁻), normal 8–12 mEq/L. HIGH AG (unmeasured anions present — MUDPILES: Methanol, Uremia, DKA/starvation ketoacidosis, Propylene glycol, Isoniazid/Iron, Lactic acidosis, Ethylene glycol, Salicylates). NORMAL AG (hyperchloremic — HCO₃⁻ lost directly): diarrhea (gut loses HCO₃⁻), renal tubular acidosis (kidney fails to excrete H⁺ or reabsorb HCO₃⁻), excessive NS infusion (excess Cl⁻ displaces HCO₃⁻). Compensation: Kussmaul respirations (deep, rapid breathing to blow off CO₂ — classic sign of DKA). Expected PaCO₂ = (1.5 × HCO₃⁻) + 8 ± 2 (Winter's formula). Nursing: IV access, continuous cardiac monitoring (acidosis causes arrhythmias), glucose and electrolytes in DKA.
Primary problem: H⁺ is lost (vomiting, NG suction — loses HCl → HCO₃⁻ relative excess; loop/thiazide diuretics — lose H⁺ and K⁺; hyperaldosteronism — aldosterone stimulates H⁺ secretion in distal tubule) or excess alkali given (antacid overuse, massive blood transfusion — citrate converts to HCO₃⁻). Always coexists with hypokalemia (K⁺ shifts into cells as H⁺ shifts out to buffer alkalosis). Hypokalemia also perpetuates alkalosis — kidney retains HCO₃⁻ to generate K⁺. Compensation: hypoventilation (limited — hypoxia limits how much CO₂ can be retained). Symptoms: muscle cramps, weakness, paresthesias (same mechanism as respiratory alkalosis — ionized Ca²⁺ falls). Nursing: treat underlying cause, KCl replacement (replaces K⁺ AND allows kidney to excrete HCO₃⁻), Mg²⁺ if depleted.
Nursing Assessment Priority: ABG Interpretation at the Bedside
A systematic 5-step ABG approach: (1) Is the patient's clinical picture consistent? (tachypnea, altered LOC, muscle cramps, etc.) (2) Check pH — acidosis (<7.35) or alkalosis (>7.45)? (3) Check PaCO₂ — ROME Respiratory Opposite: CO₂ high = acidosis contribution; CO₂ low = alkalosis contribution. (4) Check HCO₃⁻ — ROME Metabolic Equal: HCO₃⁻ low = acidosis contribution; HCO₃⁻ high = alkalosis contribution. (5) Is compensation occurring? (opposite system moving toward normal pH). Then: check PaO₂ and calculate A-a gradient if concerned about oxygenation. Report to provider: pH, the primary disorder, the level of compensation, and the patient's clinical condition. Document the result and interventions. Recheck ABG 1–2 hours after any intervention (BiPAP, bicarbonate, intubation) to assess response.
ABG: pH 7.28, PaCO₂ 58, HCO₃ 26. What is the primary disorder?
Inadequate tissue perfusion — types, recognition, and urgent intervention
Shock is not a blood pressure number — it is a state of inadequate tissue perfusion resulting in cellular hypoxia and organ dysfunction. Understanding the four shock categories by mechanism allows you to predict which patients are at risk, recognize early compensated shock before BP falls, and understand why each type demands a different intervention.
Hemodynamic Relationships
CO = HR × SV (cardiac output = heart rate × stroke volume). Normal CO: 4–8 L/min.
MAP = CO × SVR (mean arterial pressure = cardiac output × systemic vascular resistance). Target MAP ≥65 mmHg for organ perfusion.
MAP ≈ DBP + 1/3(PP) or approximately (SBP + 2×DBP)/3. A MAP of 65 = adequate perfusion pressure for most organs (cerebral autoregulation maintains flow down to MAP ~50).
Mechanism: volume loss (hemorrhage, dehydration, burns, GI losses, third-spacing) → decreased venous return → decreased preload → decreased SV → decreased CO. Compensatory response: SNS activation → tachycardia (increases HR to maintain CO), vasoconstriction (increases SVR to maintain MAP), ADH and RAAS activation (retain fluid). Hemorrhage classes: Class I (<750 mL, <15%) — minimal signs, HR <100. Class II (750–1500 mL, 15–30%) — HR 100–120, anxiety, narrowed pulse pressure. Class III (1500–2000 mL, 30–40%) — HR >120, SBP falling, oliguria, altered LOC. Class IV (>2000 mL, >40%) — HR >140, BP critically low, negligible urine output, unconscious. Treatment: stop the bleeding, restore volume. Crystalloids first (NS or LR), then blood products for hemorrhagic shock (massive transfusion: 1:1:1 ratio pRBC:FFP:platelets).
Mechanism: massive vasodilation → blood pools in periphery → inadequate central perfusion despite normal or high CO. Septic shock: cytokine-mediated (TNF-α, IL-1, IL-6) endothelial dysfunction → vasodilation + capillary leak + myocardial depression. Early: warm/flushed, bounding pulse, high CO, low SVR. Late: cold, clammy, low CO. Treatment: 30 mL/kg crystalloid bolus + norepinephrine (first-line vasopressor, alpha-1 dominant → vasoconstriction) + antibiotics within 1 hour. Anaphylactic shock: IgE-mediated mast cell degranulation → massive histamine + leukotriene release → vasodilation + bronchospasm + angioedema. Treatment: epinephrine 0.3–0.5 mg IM thigh FIRST. Neurogenic shock: spinal cord injury above T6 → loss of sympathetic tone → bradycardia + hypotension (no compensatory tachycardia — the sympathetics that would accelerate the heart are disrupted). Treatment: vasopressors (norepinephrine or phenylephrine) + atropine for bradycardia.
Mechanism: the heart cannot pump effectively → CO falls despite adequate or excessive preload. Causes: massive MI (especially anterior — LAD territory, loses large LV mass), acute decompensated heart failure, myocarditis, severe valvular disease, arrhythmia. Hemodynamic profile: low CO, high SVR (body vasoconstricts to maintain BP), high pulmonary capillary wedge pressure (preload backed up). Clinical picture: 'wet and cold' — pulmonary edema (crackles, pink frothy sputum, hypoxia) + poor perfusion (cold/clammy extremities, oliguria, AMS). JVD present. Treatment: treat MI (emergent PCI), inotropes (dobutamine — increases contractility), vasopressors if hypotension persists, consider IABP or impella mechanical support. Avoid aggressive fluids — they worsen pulmonary edema.
Mechanism: an anatomical obstruction prevents adequate cardiac output despite normal heart muscle and adequate volume. Three causes — each with a specific emergency intervention: (1) Tension pneumothorax: air accumulates in pleural space under pressure → lung collapses → mediastinum shifts → compresses opposite lung + kinks great veins → cardiac output falls. Signs: absent breath sounds (affected side), tracheal deviation (LATE sign), hypoxia, hypotension, JVD. Treatment: immediate needle decompression (2nd ICS MCL) → chest tube. (2) Cardiac tamponade: blood/fluid in pericardial sac compresses ventricles. Beck's triad: hypotension + muffled heart sounds + JVD (distended neck veins). Treatment: pericardiocentesis or emergency thoracotomy. (3) Massive PE: large thrombus blocks pulmonary circulation → RV pressure overload → RV failure → reduced LV filling → low CO. Treatment: systemic thrombolytics (tPA) or catheter-directed therapy.
Normal Blood Pressure Does NOT Rule Out Shock
The most dangerous nursing error in shock is waiting for hypotension before acting. Compensated shock maintains blood pressure through powerful sympathetic responses: tachycardia increases cardiac output, and peripheral vasoconstriction maintains mean arterial pressure. A young, healthy patient can lose 30% of their blood volume (Class III hemorrhage — up to 1,500 mL) before blood pressure drops. By the time BP falls, the patient is already severely compromised. The early signs are: tachycardia (most sensitive early sign), narrowed pulse pressure, cool/clammy extremities, delayed capillary refill (>2 seconds), and decreased urine output (<0.5 mL/kg/hr). Assess urine output every hour in any at-risk patient — it is the most sensitive clinical indicator of end-organ perfusion available at the bedside without invasive monitoring.
Nursing Assessment Priority: Recognizing Shock Before BP Falls
The shock assessment is a rapid systems survey. Mental status: early anxiety, restlessness, or agitation = brain underperfused. Progresses to confusion, obtundation, coma. Skin: pale, mottled, cool and clammy = compensatory vasoconstriction (exception: distributive shock = warm, flushed early). Capillary refill >2 seconds. Pulse: tachycardia is the FIRST compensatory sign. Weak, thready pulse with narrowed pulse pressure = low stroke volume. Blood pressure: late to fall in compensated shock. When it falls, it falls fast — patients 'fall off a cliff.' Respiration: tachypnea develops from lactic acidosis stimulating respiratory compensation and from tissue hypoxia. Urine output: <0.5 mL/kg/hr = renal hypoperfusion. Insert Foley in any patient at risk for shock. Lactic acid: >2 mmol/L = anaerobic metabolism occurring despite possibly normal BP. Serial lactate q2h guides resuscitation adequacy. Document every 15 minutes in active shock.
From localized infection to life-threatening organ failure
Sepsis kills more people annually than many cancers combined. It is not simply 'bad infection' — it is a pathological host response that turns the immune system against the patient's own organs. Early recognition is everything: each hour of delay in antibiotics increases mortality by 7%. Understanding the molecular cascade empowers you to act on early subtle signs rather than waiting for obvious deterioration.
Sepsis-3 Definitions (2016)
Infection: pathogenic microorganism invading host tissue → host immune response.
Sepsis: life-threatening organ dysfunction caused by a dysregulated host response to infection. SOFA score ≥2 from baseline. Quick SOFA (qSOFA ≥2 at bedside): altered mentation (GCS <15) + respiratory rate ≥22 + systolic BP ≤100.
Septic shock: sepsis + need for vasopressor to maintain MAP ≥65 mmHg + serum lactate >2 mmol/L despite adequate fluid resuscitation. Mortality >40%.
Pathophysiology: From Microbe to Multi-Organ Failure
Step 1 — Recognition: PAMPs (pathogen-associated molecular patterns — LPS from gram-negative bacteria, peptidoglycan from gram-positive) bind PRRs (pattern recognition receptors — Toll-like receptors on macrophages and neutrophils) → immediate immune activation.
Step 2 — Cytokine storm: Massive release of TNF-α, IL-1β, IL-6 → endothelial activation → expression of adhesion molecules, tissue factor, increased permeability. Simultaneously: complement activation, kallikrein-kinin system activation (bradykinin → vasodilation + pain).
Step 3 — Endothelial dysfunction: Capillary leak → fluid shifts to interstitium → intravascular depletion despite total body fluid excess (third-spacing). Microthrombi form in small vessels (microvascular occlusion → tissue hypoxia).
Step 4 — Organ failure (SOFA organs): Lungs (ARDS — P/F ratio <300), Kidneys (oliguria, rising creatinine — AKI), Liver (rising bilirubin — hepatocyte hypoxia), Cardiovascular (hypotension, vasopressor requirement), CNS (altered mentation — GCS drop), Coagulation (falling platelets — DIC).
DIC — Disseminated Intravascular Coagulation
DIC is the pathological paradox: simultaneous widespread clotting AND bleeding. Sepsis, trauma, obstetric emergencies (amniotic fluid embolism, placental abruption), and malignancy trigger massive activation of the coagulation cascade. Microthrombi form throughout the microcirculation → consume clotting factors and platelets faster than the liver can replenish them → the patient is simultaneously clotting (ischemic organ damage) and bleeding (from lack of factors).
Labs: ↓Platelets (consumed), ↓Fibrinogen (consumed), ↑PT/INR (factor depletion), ↑aPTT, ↑D-dimer (fibrin degradation products — elevated due to fibrinolysis of clots), ↑Fibrin split products. Schistocytes on peripheral smear (RBCs sheared by fibrin strands).
Treatment: Treat the underlying cause (antibiotics for sepsis, deliver fetus in obstetric DIC). Supportive: FFP (replaces clotting factors), cryoprecipitate (replaces fibrinogen — give if <100 mg/dL), platelets (give if <50,000 with bleeding or <20,000 prophylactically). Heparin is controversial and rarely used except in thrombosis-dominant DIC.
Why Lactate Is the Critical Sepsis Metabolic Marker
Lactate is elevated in sepsis because tissues are not receiving adequate oxygen delivery relative to their metabolic demands. When oxygen delivery fails, cells switch from aerobic metabolism (36–38 ATP per glucose) to anaerobic glycolysis (2 ATP per glucose), which produces pyruvate faster than the citric acid cycle can consume it. Excess pyruvate is converted to lactate by lactate dehydrogenase. Serum lactate >2 mmol/L indicates tissue hypoperfusion even when blood pressure appears normal. Lactate >4 mmol/L with hypotension defines septic shock and carries >40% mortality. Serial lactate measurements guide resuscitation — a lactate that clears (drops by >10% after 2 hours of fluids) suggests adequate resuscitation. A persistently elevated lactate despite fluid resuscitation suggests need for vasopressors (norepinephrine first-line) and signals higher mortality risk.
Nursing Assessment Priority: SEP-1 Bundle and Early Recognition
The SEP-1 bundle is a 1-hour bundle (Centers for Medicare and Medicaid Services, evidence-based): within 1 hour of sepsis recognition: (1) Measure serum lactate — if ≥2 mmol/L, repeat at 2 hours. (2) Obtain blood cultures ×2 (different sites) BEFORE antibiotics. (3) Administer broad-spectrum antibiotics. (4) 30 mL/kg IV crystalloid bolus if MAP <65 OR lactate ≥4 mmol/L. (5) Vasopressors if hypotension persists after fluid challenge — target MAP ≥65. Nursing assessment triggers for sepsis concern: new altered mentation in any patient with known or suspected infection; respiratory rate ≥22; systolic BP ≤100; temperature >38°C or <36°C; HR >90; WBC >12,000 or <4,000. The qSOFA score (≥2 of: altered mentation, RR ≥22, SBP ≤100) at the bedside predicts ICU-level care need. Document assessment time — the clock starts at recognition, not when the provider orders labs.
When the immune system attacks the wrong target
The immune system's power to destroy pathogens can be turned against the host — through hypersensitivity reactions (overreaction to allergens) or autoimmunity (immune attack on self). These conditions affect virtually every organ system and require nurses to understand not just the drug treatments but the underlying immunological mechanisms driving the disease.
Mechanism: First exposure (sensitization) → allergen causes B cells to produce allergen-specific IgE → IgE binds to Fc receptors on mast cells and basophils. Second exposure → allergen cross-links two IgE molecules on the mast cell surface → immediate degranulation → histamine, tryptase, leukotrienes, prostaglandins released. Timeline: within minutes. Clinical spectrum: mild (allergic rhinitis — sneezing, itchy eyes) → moderate (urticaria, angioedema, asthma flare) → severe (anaphylaxis — systemic vasodilation + bronchospasm + angioedema → shock). Diagnosis: skin prick testing, serum allergen-specific IgE (RAST), serum tryptase (elevated in anaphylaxis — distinguishes from vasovagal). Treatment: antihistamines and steroids for mild. Epinephrine for anaphylaxis — no substitute.
Mechanism: IgG or IgM antibodies bind to cell surface or extracellular matrix antigens → complement activation (C1q binds Fc region → classical pathway → MAC lysis) OR opsonization (C3b + IgG coat cells for phagocytosis) OR ADCC (antibody-dependent cellular cytotoxicity — NK cells bind Fc region of bound antibody → release perforin/granzymes). Clinical examples: (1) Autoimmune hemolytic anemia — anti-RBC antibodies → RBC destruction → jaundice, anemia, elevated LDH/indirect bilirubin. (2) Goodpasture syndrome — anti-GBM antibodies → glomerulonephritis + pulmonary hemorrhage. (3) Myasthenia gravis — anti-AChR antibodies block acetylcholine receptors at NMJ → ptosis, diplopia, proximal weakness, respiratory failure in crisis. (4) Graves disease — TSH receptor stimulating antibodies → hyperthyroidism. (5) ABO incompatible transfusion — intravascular hemolysis, hemoglobinuria, DIC, AKI.
Mechanism: soluble antigen-antibody complexes form in the circulation → normally cleared by phagocytes, but when complement is deficient or complexes are large → they deposit in small blood vessel walls, glomeruli, and synovial membranes → activate complement → C3a/C5a recruit neutrophils → neutrophil degranulation damages the vessel wall → vasculitis, glomerulonephritis, synovitis. Clinical examples: (1) SLE (systemic lupus erythematosus) — anti-dsDNA and anti-Smith antibodies → immune complexes in glomeruli (lupus nephritis — hematuria, proteinuria, hypertension), skin vessels (vasculitis, butterfly rash), joints (arthritis). (2) Post-streptococcal glomerulonephritis — follows strep throat by 10–14 days; immune complexes with streptococcal antigens deposit in glomerular basement membrane. (3) Serum sickness — immune complexes to foreign proteins (antivenom, chimeric antibodies) → fever, rash, arthralgias 7–14 days after exposure.
Mechanism: sensitized CD4⁺ T cells (Th1) recognize antigen presented by APC → release IFN-γ → activate macrophages → macrophage-mediated tissue damage. CD8⁺ cytotoxic T cells directly kill antigen-bearing cells (transplant rejection). Timeline: 24–72+ hours (no antibodies involved — this is why antihistamines do NOT work). Clinical examples: (1) Contact dermatitis — poison ivy (urushiol hapten binds to skin proteins → sensitizes T cells → re-exposure → pruritic vesicular rash in 24–72h). (2) Mantoux/PPD test — intradermal tuberculin → if sensitized, T cells infiltrate → induration at 48–72h (≥10 mm = positive in most groups). (3) Chronic transplant rejection — ongoing CD4⁺/CD8⁺ T-cell attack on allograft antigens. (4) Stevens-Johnson syndrome/TEN — drug-specific CD8⁺ T cells attack keratinocytes expressing drug-modified MHC → epidermal necrosis and sloughing (>30% BSA in TEN — life-threatening, treat as burn).
Common Autoimmune Diseases: Nursing-Relevant Mechanisms
SLE
Anti-dsDNA, anti-Smith (anti-Sm) antibodies. Type III immune complex. Butterfly (malar) rash, photosensitivity, serositis, renal involvement. Flares triggered by UV exposure, infections, medications. Monitor anti-dsDNA levels (correlate with disease activity), complement (C3/C4 fall during flares — consumed by immune complexes).
Rheumatoid Arthritis
RF (IgM anti-IgG Fc) and anti-CCP antibodies (more specific). Symmetric synovial inflammation → pannus formation → joint erosion. Morning stiffness >1 hour. DMARDs (methotrexate, hydroxychloroquine) slow progression. Biologic DMARDs: anti-TNF (infliximab, adalimumab) and anti-IL-6 (tocilizumab). Monitor LFTs with methotrexate (hepatotoxic).
Type 1 Diabetes
Anti-islet cell antibodies (anti-GAD65, anti-IA-2, anti-ZnT8) destroy pancreatic beta cells → absolute insulin deficiency → DKA susceptibility. Autoimmune in nature — HLA DR3/DR4 association. Screen first-degree relatives.
Hashimoto's Thyroiditis
Anti-TPO (thyroid peroxidase) and anti-thyroglobulin antibodies. Type IV (lymphocyte infiltration) + Type II. Progressive destruction of thyroid → hypothyroidism. Most common cause of hypothyroidism in iodine-sufficient countries. TSH rises as thyroid fails.
Anaphylaxis: Epinephrine FIRST — No Exceptions
Anaphylaxis nursing priorities follow a strict sequence because delays cost lives. (1) Epinephrine FIRST — 0.3–0.5 mg (adults) or 0.01 mg/kg (children, max 0.5 mg) IM into the anterolateral thigh. Do NOT delay for antihistamines or steroids — they do not reverse bronchospasm or anaphylactic shock. Epinephrine reverses all three life-threatening mechanisms: alpha-1 vasoconstriction reverses hypotension, beta-2 bronchodilation reverses bronchospasm, beta-1 increases cardiac output. (2) Position supine with legs elevated (or semi-recumbent if respiratory distress predominates). (3) Establish IV access — large-bore. (4) IV fluids for hypotension — NS bolus. (5) Diphenhydramine 25–50 mg IV/IM — blocks H1 receptors, reduces urticaria/angioedema progression. (6) Ranitidine or famotidine — H2 blockade. (7) Methylprednisolone 125 mg IV — prevents biphasic reaction (can occur 4–8 hours later). (8) Albuterol nebulizer for persistent bronchospasm. NEVER send an anaphylaxis patient home after just epinephrine — observe minimum 4–6 hours for biphasic reaction.
Nursing Assessment Priority: Immune-Mediated Disease Monitoring
Autoimmune and hypersensitivity diseases require monitoring across multiple body systems simultaneously. For any patient on immunosuppressants (steroids, methotrexate, biologics): infection risk is your primary safety concern. Daily vital signs assessment for fever. Respiratory: opportunistic infections (PCP pneumonia in steroid-dependent patients — fever, dry cough, hypoxia — prophylax with trimethoprim-sulfamethoxazole if on high-dose steroids). Skin: wound healing is impaired by steroids (fibroblast suppression). GI: NSAIDs and steroids together dramatically increase peptic ulcer risk — add a PPI. Bone: chronic steroids cause osteoporosis (prescribe calcium + vitamin D + consider bisphosphonate). Lab monitoring depends on the agent: methotrexate requires LFTs and CBC (hepatotoxicity, myelosuppression); hydroxychloroquine requires ophthalmology checks (retinal toxicity); biologics require TB screening before initiation (latent TB can reactivate — test with IGRA, not PPD which may be falsely negative in immunocompromised).
Inheritance patterns, chromosomal disorders, and nursing implications
Genetic diseases illustrate fundamental principles of how the genome translates into disease. Understanding inheritance patterns allows you to counsel patients about family risk, recognize presentations in unexpected demographics, and connect molecular mechanisms to clinical findings. Many common diseases have genetic components nurses encounter daily.
Mechanism: the mutant allele either produces a toxic gain-of-function protein OR haploinsufficiency (one copy of the gene is not enough for normal function). Key diseases: (1) Huntington disease — expanded CAG repeat in HTT gene → polyglutamine tract → misfolded protein aggregates destroy striatal neurons → chorea, psychiatric symptoms, dementia; onset typically 30–50; autosomal dominant with 100% penetrance if gene present; no cure, only symptomatic management. (2) Marfan syndrome — FBN1 mutation (fibrillin-1) → connective tissue weakness → aortic aneurysm/dissection risk, lens dislocation (ectopia lentis), tall stature, pectus excavatum, arachnodactyly. Measure aortic root diameter annually. (3) BRCA1/2 — tumor suppressor genes; heterozygous mutations increase breast cancer risk dramatically. (4) Familial hypercholesterolemia — LDL receptor defect → severely elevated LDL → premature atherosclerosis. Risk per child: 50% regardless of sex.
Mechanism: both copies of the gene must be non-functional. Parents are typically carriers (heterozygous — one functional allele sufficient). Risk matrix: carrier × carrier → 25% affected, 50% carrier, 25% unaffected. Key diseases: (1) Cystic fibrosis — CFTR mutation (most common: ΔF508 deletion) → defective Cl⁻ channel → thick, viscous mucus in airways (chronic infections, bronchiectasis), pancreatic ducts (exocrine insufficiency, fat malabsorption, fat-soluble vitamin deficiency), sweat glands (elevated sweat Cl⁻ >60 mEq/L — sweat chloride test). Median survival now >47 years with CFTR modulator therapy (ivacaftor/elexacaftor/tezacaftor — corrects protein misfolding). (2) Sickle cell disease — HbS (Val→Glu substitution at β-globin position 6) → deoxygenation → HbS polymerizes → RBC sickling → vaso-occlusion (pain crises, stroke, acute chest syndrome, splenic infarction) + hemolytic anemia. (3) PKU — phenylalanine hydroxylase (PAH) deficiency → phenylalanine accumulates → neurotoxic → intellectual disability if untreated; detected by newborn screening; treat with low-phenylalanine diet. (4) Tay-Sachs — hexosaminidase A deficiency → GM2 ganglioside accumulates in neurons → progressive neurodegeneration from infancy.
Mechanism: the gene is on the X chromosome. Males have only one X — if it carries the mutant allele, disease results (hemizygous). Females need two mutant X alleles to be affected; with one, they are carriers who may have mild symptoms. No father-to-son transmission (fathers give Y to sons, X to daughters). Key diseases: (1) Hemophilia A — Factor VIII deficiency → intrinsic pathway coagulation defect → prolonged aPTT, normal PT → spontaneous joint bleeds (hemarthrosis), muscle hematomas, intracranial hemorrhage. Treatment: recombinant Factor VIII concentrate; emicizumab (bispecific antibody bridging IXa and X — given subcutaneously as prophylaxis). (2) Duchenne muscular dystrophy (DMD) — dystrophin gene mutation (largest gene in the human genome, high spontaneous mutation rate) → absence of dystrophin protein → progressive muscle fiber breakdown → wheelchair by teens, cardiomyopathy, respiratory failure; elevated CK markedly from early childhood. (3) G6PD deficiency — oxidative stress (fava beans, primaquine, dapsone, infections) → oxidized hemoglobin → Heinz body formation → hemolytic anemia; screen before prescribing oxidant drugs.
Mechanism: non-disjunction in meiosis I or II → gamete with wrong chromosome number → aneuploidy after fertilization. (1) Trisomy 21 (Down syndrome) — most common chromosome disorder; risk increases sharply with maternal age. Features: intellectual disability (variable), hypotonia, flat facial profile, epicanthal folds, single palmar crease (Simian crease), atlantoaxial instability, congenital heart disease (50% — ASD, VSD, AV canal), duodenal atresia, increased risk of ALL and AML, Alzheimer disease development by 50s. (2) Trisomy 18 (Edwards) and Trisomy 13 (Patau) — severe multi-organ anomalies; most die in infancy. (3) Klinefelter syndrome (47,XXY) — most common sex chromosome disorder in males; azoospermia, infertility, tall stature, gynecomastia, small testes, testosterone deficiency → osteoporosis, metabolic syndrome; often diagnosed during infertility workup. (4) Turner syndrome (45,X) — only viable monosomy; short stature (GH therapy), ovarian dysgenesis (streak gonads → primary amenorrhea), coarctation of the aorta (20%), horseshoe kidney, lymphedema at birth (webbed neck, cystic hygroma).
Carrier Testing and the Nursing Role in Genetic Counseling
Genetic counseling nursing assessment begins with a three-generation pedigree (proband, parents, grandparents, siblings, children). Key questions: Are there family members with similar conditions? At what age? Any consanguinity? The nurse's role is not genetic counseling per se — that belongs to certified genetic counselors — but includes: (1) obtaining the genetic history accurately, (2) recognizing patterns that suggest genetic etiology (young-onset disease, multiple family members, bilateral or multifocal presentations, disease in unusual-gender individuals — e.g., breast cancer in males suggests BRCA2), (3) understanding implications for the patient, including insurance discrimination concerns (GINA protects against health insurance and employment discrimination based on genetic information), and (4) supporting patients emotionally after genetic test results — a positive BRCA1 result, for example, requires extensive psychological support alongside medical management discussions.
Nursing Assessment Priority: Recognizing Genetic Disease Presentations
Genetic disease should be considered when: (1) Disease onset is unusually young (MI at 35 in someone with familial hypercholesterolemia — xanthomas, arcus cornea, LDL >300 mg/dL). (2) Multiple family members across generations are affected in the same way (suggests autosomal dominant). (3) Only males in a family are affected (suggests X-linked). (4) Parents are consanguineous (increases autosomal recessive risk). (5) The presentation is multisystem (a 20-year-old with kidney cysts + liver cysts + berry aneurysm = ADPKD). Nursing roles: accurate family history documentation (three-generation pedigree), understanding implications of genetic test results for patient and family, psychosocial support (genetic diagnosis has profound implications for life planning, reproduction, insurance), connecting patients with certified genetic counselors, and being aware of GINA protections. Never interpret a genetic test result directly to the patient without provider involvement — the implications require comprehensive counseling.
Hormonal axis dysfunction: hypo-, hyper-, and axis failures
Endocrine diseases are disorders of too much or too little hormone — but understanding WHY helps you predict lab patterns, clinical presentations, and treatment priorities. The key is the feedback axis: when a peripheral gland fails, the pituitary senses low feedback and increases tropic hormone output. When a peripheral gland is overactive, it suppresses the pituitary. This axis logic applies to every endocrine system.
Primary Failure
Primary hypothyroidism: thyroid fails → ↓T3/T4 → ↑TSH (pituitary senses low feedback, increases output). The ↑TSH is the diagnostic clue.
Primary Excess
Graves disease or toxic adenoma: thyroid overproduces T3/T4 → ↓TSH (negative feedback suppresses pituitary). Low TSH is diagnostic.
Secondary Failure
Pituitary tumor destroys TSH-secreting cells → ↓TSH → peripheral thyroid atrophies → ↓T3/T4. Both TSH AND T3/T4 are low — distinguishes from primary.
T1DM: autoimmune destruction of pancreatic beta cells (anti-GAD65, anti-IA-2, anti-ZnT8 antibodies) → absolute insulin deficiency. Without insulin: (1) glucose cannot enter cells → hyperglycemia → glycosuria → osmotic diuresis → polyuria/polydipsia. (2) Fat breakdown uninhibited → free fatty acids → liver oxidizes to acetyl-CoA → overwhelms TCA cycle → ketone bodies (acetoacetate, beta-hydroxybutyrate, acetone). (3) DKA: pH <7.3, HCO₃ <15, anion gap >12, blood/urine ketones positive, glucose typically >250 mg/dL. Kussmaul respirations compensate. Fruity breath (acetone). Treat: IV insulin infusion (0.1 units/kg/hr), NS/LR fluids (correct hypovolemia from osmotic diuresis), potassium replacement (insulin shifts K⁺ into cells — hypokalemia is the most dangerous DKA complication — DO NOT start insulin without ensuring K⁺ ≥3.3). T2DM: insulin resistance (visceral fat adipokines — resistin, TNF-α — impair insulin receptor signaling) → compensatory hyperinsulinemia → beta cell exhaustion → relative insulin deficiency. HHS (Hyperosmolar Hyperglycemic State): T2DM + stressor → glucose >600 mg/dL + serum osmolality >320 mOsm/kg → profound dehydration + altered LOC + NO significant ketosis (residual insulin inhibits lipolysis enough to prevent ketogenesis). Very high mortality (~15%).
Hypothyroidism (↓T3/T4, ↑TSH): most common endocrine disorder. Primary cause: Hashimoto's thyroiditis (autoimmune). Symptoms reflect ↓metabolic rate: fatigue, cold intolerance, weight gain, constipation, bradycardia, dry skin, hair loss, menstrual irregularities, depression, cognitive slowing, myxedema (non-pitting edema from glycosaminoglycan accumulation). Severe: myxedema coma — hypothermia, bradycardia, hypoventilation, altered LOC — triggered by cold exposure, infection, surgery. Treat: IV T4 (levothyroxine) + T3 (liothyronine) + hydrocortisone (concurrent adrenal insufficiency in hypothalamic/pituitary hypothyroidism). Hyperthyroidism (↑T3/T4, ↓TSH): Graves disease (TSH receptor stimulating antibodies — Type II hypersensitivity). Symptoms: heat intolerance, weight loss despite increased appetite, tachycardia/atrial fibrillation, tremor, proximal muscle weakness, exophthalmos (TSH receptor on orbital fibroblasts → proptosis), pretibial myxedema. Thyroid storm: fever >38.5°C, HR >140 (can cause high-output cardiac failure), agitation/confusion, GI symptoms. Treat: PTU (blocks synthesis AND conversion of T4→T3) + potassium iodide (Wolff-Chaikoff effect — blocks iodine uptake, give 1 hour AFTER PTU) + propranolol (blocks sympathomimetic effects of T3 + blocks T4→T3 conversion) + dexamethasone (blocks T4→T3, treats relative adrenal insufficiency).
Addison's disease (primary adrenal insufficiency): autoimmune destruction of adrenal cortex (anti-21-hydroxylase antibodies in most Western cases; TB adrenalitis historically common). Destroys all three zones → ↓cortisol + ↓aldosterone + ↓adrenal androgens. Loss of negative feedback on pituitary → massive ↑ACTH. ACTH shares structure with MSH → hyperpigmentation (bronze skin, especially in sun-exposed areas, gum lines, knuckles, scars). Aldosterone loss → sodium wasting + potassium retention → hyponatremia + hyperkalemia. Cortisol loss → hypoglycemia (cortisol is a counter-regulatory hormone). Signs: weakness, weight loss, salt craving, postural hypotension. Adrenal crisis: precipitated by physiological stress in undiagnosed or under-replaced patients → shock, hyponatremia, hyperkalemia, hypoglycemia. Treatment: hydrocortisone 100 mg IV bolus, then 50 mg q6–8h; NS and dextrose IV; identify and treat the precipitant. Cushing syndrome (excess glucocorticoid): most common cause is exogenous steroid use (iatrogenic). Endogenous: Cushing disease (ACTH-secreting pituitary adenoma, most common endogenous), ectopic ACTH (small cell lung cancer, carcinoid), adrenal adenoma. Features: central obesity (cortisol stimulates visceral fat deposition), moon face, buffalo hump (supraclavicular fat pads), violaceous striae (skin collagen breakdown), proximal muscle weakness, osteoporosis (inhibits osteoblasts), hyperglycemia, hypertension, hypokalemia, immunosuppression (neutrophilia — lymphocytes and eosinophils decrease), depression/psychosis.
ADH (antidiuretic hormone, vasopressin) is made in the hypothalamus, stored/released from the posterior pituitary. Actions: binds V2 receptors on renal collecting duct → inserts aquaporin-2 water channels → free water reabsorption. SIADH (Syndrome of Inappropriate ADH secretion): excessive ADH released despite normal or low osmolality → excessive water retention → dilutional hyponatremia + concentrated urine (urine osmolality >100, usually >300 mOsm/kg) + urine Na >20 mEq/L. Causes: CNS lesions (trauma, hemorrhage, meningitis), pulmonary disease (pneumonia, TB, ARDS — ectopic ADH production), pain, nausea, many drugs (SSRIs, carbamazepine, oxytocin, cyclophosphamide, NSAIDs). Treatment: fluid restriction (600–1000 mL/day) is first-line. For severe symptomatic hyponatremia: hypertonic (3%) saline cautiously. Vaptans (tolvaptan — V2 receptor antagonist) cause aquaresis. Diabetes Insipidus (DI): central DI — ADH deficiency (head trauma, pituitary surgery, hypothalamic tumor) → massive dilute urine (urine osmolality <200 mOsm/kg) + hypernatremia + extreme thirst. Nephrogenic DI — ADH present but kidney unresponsive (lithium toxicity, hypercalcemia, CKD). Treatment: central DI → DDAVP (desmopressin, a V2 agonist) nasal spray or IV. Nephrogenic DI → treat cause, thiazide diuretics (paradoxically reduce urine output by inducing mild Na depletion → increases proximal reabsorption), low-sodium diet.
Steroid-Dependent Patients Need Stress Doses — Always Ask
Patients on chronic corticosteroids (prednisone, hydrocortisone, dexamethasone) have suppressed hypothalamic-pituitary-adrenal (HPA) axes. Their adrenal glands have atrophied from disuse because exogenous steroid suppresses ACTH release. Under physiological stress — surgery, severe infection, trauma — the normal adrenal glands would produce 200–500 mg/day of cortisol (compared to basal 20 mg/day). A patient on chronic steroids CANNOT mount this response. Without a stress dose of steroids (hydrocortisone 50–100 mg IV every 8 hours), these patients develop adrenal crisis: refractory hypotension, hyponatremia, hyperkalemia, hypoglycemia. Always ask about steroid use in pre-operative assessment. Any patient on >5 mg prednisone/day for >3 weeks who presents with unexplained hypotension should receive empiric hydrocortisone while being evaluated.
Nursing Assessment Priority: Endocrine Emergency Recognition
Four endocrine emergencies every nurse must recognize instantly: (1) DKA: fruity breath, Kussmaul respirations (deep sighing breaths), altered LOC, polyuria/polydipsia history, glucose >250. Priorities: IV access (large-bore ×2), NS 1 L/hr initially, continuous insulin drip protocol, hourly glucose and potassium monitoring, cardiac monitoring for hypo/hyperkalemia. (2) HHS: extreme hyperglycemia (>600), profound dehydration, altered consciousness, NO Kussmaul breathing (no ketoacidosis). Very high fluid deficit (5–10 L). Slow fluid replacement to avoid cerebral edema. (3) Thyroid storm: fever + tachycardia + altered LOC in a patient with known or suspected hyperthyroidism. Ice packs for hyperthermia, continuous cardiac monitoring (AF risk), propranolol IV, PTU, call provider immediately. (4) Adrenal crisis: unexplained refractory hypotension + hyponatremia + hyperkalemia in a patient on or recently stopped steroids, or with known adrenal insufficiency. Give hydrocortisone 100 mg IV NOW — before lab confirmation if clinical suspicion is high. The blood cortisol can be drawn before giving the drug.
Atherosclerosis through heart failure — the mechanism continuum
Cardiovascular disease is the leading cause of death in the United States. The progression from atherosclerosis to unstable plaque to MI to heart failure follows a logical mechanistic continuum. Understanding each step helps nurses recognize where on this continuum each patient sits, anticipate complications, and understand why specific treatments target specific steps.
Atherosclerosis Pathogenesis — Step by Step
Mechanism: atherosclerotic plaque causes fixed coronary stenosis (typically >70% luminal narrowing). At rest, flow is adequate. With exertion or emotional stress (↑HR, ↑BP, ↑myocardial O₂ demand), supply cannot increase → ischemia. Typical presentation: predictable chest pressure/tightness on exertion, relieved by rest within 2–5 minutes or by sublingual nitroglycerin (vasodilates coronary arteries + reduces preload). ECG: may show ST depression or T-wave changes during pain (ischemia = ST depression, not elevation). Treatment: anti-anginal medications (nitrates, beta-blockers — ↓HR and O₂ demand, calcium channel blockers), antiplatelet therapy (aspirin), statins (plaque stabilization), revascularization if refractory (PCI or CABG).
The ACS continuum is defined by degree of occlusion and biomarker elevation: Unstable angina (UA): plaque rupture + platelet aggregation + partial thrombus → supply/demand mismatch at rest. Troponin NORMAL. ECG: ST depression or transient ST changes or normal. NSTEMI: partial occlusion → subendocardial infarction (innermost myocardium, most vulnerable — farthest from coronary supply). Troponin ELEVATED. ECG: ST depression, T-wave inversion, or dynamic changes. STEMI: complete occlusion → transmural infarction (full thickness). Troponin ELEVATED. ECG: ST ELEVATION in two contiguous leads (or new LBBB — consider STEMI-equivalent). ST elevation = emergency → goal is door-to-balloon time ≤90 minutes (primary PCI) or ≤30 minutes for thrombolytics if no cath lab available. STEMI treatment sequence: aspirin 325 mg + P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) + heparin + oxygen (if SpO₂ <90%) + call cath lab immediately.
Heart failure is not just a weak heart — it is a progressive syndrome where compensatory mechanisms become pathological. Trigger: MI, hypertension, valvular disease, cardiomyopathy → ↓cardiac output. Compensatory responses: (1) SNS activation — ↑HR + ↑contractility (short-term helpful, long-term → myocardial oxygen demand, arrhythmias, beta-receptor downregulation). (2) RAAS activation — angiotensin II → vasoconstriction (↑afterload → ↑wall stress → worsens function) + aldosterone → Na⁺/H₂O retention (↑preload) → ↑ventricular wall stress → remodeling (dilation, fibrosis). (3) ADH → water retention → preload further increases. (4) Ventricular remodeling: myocyte hypertrophy + fibrosis + dilation → spherical LV → worsens ejection fraction. Why ACE inhibitors, ARBs, and beta-blockers improve mortality in HF: they interrupt these compensatory neurohormonal cascades.
Left-sided HF: LV cannot pump blood forward → blood backs up into pulmonary veins → pulmonary capillary wedge pressure rises → fluid transudates into alveoli → pulmonary edema. Symptoms: dyspnea on exertion → rest → orthopnea (requires 2+ pillows) → PND (paroxysmal nocturnal dyspnea — awakens gasping 1–2 hours after lying flat). Signs: bilateral basal crackles, S3 gallop (rapid ventricular filling in dilated LV — 'Ken-tuc-ky' sound at apex), reduced CO (cool extremities, pale, oliguria, AMS, fatigue). Right-sided HF: RV cannot pump blood into pulmonary circulation → blood backs up into systemic veins. Most common cause is left-sided HF (pulmonary hypertension from chronic LV failure overloads RV). Also: cor pulmonale (COPD → pulmonary HTN → right HF). Signs: JVD (hepatojugular reflux), pitting peripheral edema (bilateral dependent — ankle/pretibial, sacral in bedridden), hepatomegaly + right upper quadrant tenderness (hepatic congestion → cardiac cirrhosis long-term), ascites.
Nursing Assessment Priority: Cardiovascular Head-to-Toe
The cardiovascular assessment follows a systematic head-to-toe approach that maps directly to the pathophysiology. Left heart failure causes pulmonary venous congestion: auscultate for bibasilar crackles (fluid in alveoli), note orthopnea (how many pillows?), paroxysmal nocturnal dyspnea (waking gasping from sleep when recumbent redistributes fluid centrally), pink frothy sputum (severe pulmonary edema). Reduced cardiac output signs: S3 gallop (ventricular filling sound in dilated, failing ventricle), cool and mottled extremities (vasoconstriction), altered mental status (poor cerebral perfusion), oliguria. Right heart failure causes systemic venous congestion: JVD (assess at 45° angle — normal JVP <4 cm above the sternal angle), hepatomegaly with right upper quadrant tenderness (hepatic congestion), dependent pitting edema (grade 1–4), ascites. Track daily weights — 1 kg = approximately 1 liter of fluid retained.
Obstructive vs restrictive — mechanisms, spirometry, and clinical management
Respiratory diseases divide cleanly into obstructive (airflow limitation on exhalation) and restrictive (reduced lung volume). Understanding this distinction explains why a COPD patient breathes differently from an ARDS patient, why the same medication (bronchodilators) helps one and not the other, and why oxygen therapy must be titrated carefully.
Obstructive Pattern (Spirometry)
FEV₁/FVC ratio <0.70 (reduced — can't exhale fast). FEV₁ reduced. FVC may be normal or increased (in emphysema — hyperinflation). Total lung capacity (TLC) increased (air trapping). Residual volume (RV) increased. Diseases: COPD (emphysema + chronic bronchitis), asthma, bronchiectasis, cystic fibrosis.
Clinical: barrel chest (increased AP diameter from hyperinflation), pursed-lip breathing, prolonged expiratory phase, accessory muscle use, distant breath sounds.
Restrictive Pattern (Spirometry)
FEV₁/FVC ratio NORMAL or increased (both reduced proportionally, but FVC drops more). TLC reduced. RV reduced or normal. Diseases: pulmonary fibrosis (IPF, asbestosis), ARDS, pleural effusion, neuromuscular weakness (diaphragm weakness in Guillain-Barré), obesity hypoventilation, kyphoscoliosis.
Clinical: rapid shallow breathing (small tidal volumes, can't expand stiff lungs), fine Velcro crackles (IPF), hypoxia refractory to O₂ (ARDS — shunt physiology).
COPD is a unified disease of two overlapping components: Emphysema: smoking activates alveolar macrophages → release neutrophil elastase (and other proteases) → breaks down elastin and collagen in alveolar walls → alveolar destruction → loss of surface area (↓gas exchange) + loss of elastic recoil (alveoli cannot spring back → air trapping). Protease-antiprotease imbalance: alpha-1 antitrypsin (AAT) normally inhibits neutrophil elastase. Smoking overwhelms AAT. AAT deficiency gene mutation causes early-onset COPD in non-smokers. Chronic bronchitis: defined CLINICALLY as productive cough for ≥3 months/year for ≥2 consecutive years. Mechanism: smoking → mucus gland hypertrophy + goblet cell metaplasia in small airways → mucus hypersecretion + ciliary dysfunction (smoking paralyzes cilia) → chronic infection and inflammation. Cor pulmonale: chronic hypoxia → pulmonary arterial vasoconstriction (Euler-Liljestrand reflex) → pulmonary hypertension → right ventricular hypertrophy and failure. Treatment goals: maximize bronchodilation (LABA + LAMA — long-acting beta-agonists and muscarinic antagonists), reduce exacerbations (ICS in selected patients, roflumilast for severe), smoking cessation (single most effective intervention), pulmonary rehabilitation.
Asthma is characterized by airway hyperresponsiveness to triggers — the asthmatic airway reacts to stimuli that do not affect normal airways. Pathophysiology: exposure to trigger (allergen, exercise, cold air, viral infection, aspirin/NSAIDs, beta-blockers) → early phase (minutes): mast cell IgE-mediated release of histamine and leukotrienes → bronchospasm + mucus secretion. Late phase (4–8 hours): eosinophil infiltration → release of major basic protein and eosinophil peroxidase → epithelial damage + sustained inflammation → airway remodeling (subepithelial fibrosis, smooth muscle hypertrophy, goblet cell hyperplasia) in chronic poorly-controlled asthma. Distinction from COPD: asthma is REVERSIBLE — FEV₁ improves ≥12% (and ≥200 mL) after bronchodilator (albuterol). COPD is irreversible. Some patients have both (ACOS — asthma-COPD overlap syndrome). Status asthmaticus: severe, prolonged bronchospasm unresponsive to rescue bronchodilators. Hallmarks: SpO₂ falling despite maximal therapy, PEFR <50% predicted, pulsus paradoxus >10 mmHg, inability to speak in sentences. A 'silently wheeze-free' patient in status asthmaticus is alarming — no airflow = no wheeze. Prepare for intubation.
ARDS is a clinical syndrome, not a disease — it is the lung's response to a severe systemic or direct insult. Berlin definition requires: acute onset within 1 week, bilateral opacities on CXR/CT not explained by effusion/collapse/nodules, PaO₂/FiO₂ (P/F) ratio: Mild <300, Moderate <200, Severe <100 (all on PEEP ≥5 cmH₂O), not fully explained by heart failure. Pathophysiology — three phases: (1) Exudative (days 1–7): the alveolar-capillary barrier is destroyed by neutrophil-mediated injury (elastase, oxidants), cytokines (IL-8, IL-1β), and complement. Protein-rich fluid floods alveoli → surfactant inactivated (surfactant is a phospholipid that reduces surface tension; when inactivated, alveoli collapse on exhalation). (2) Proliferative (days 7–21): type II pneumocyte proliferation attempts to repair; fibroblast infiltration begins. (3) Fibrotic: some patients develop progressive fibrosis → permanent restrictive lung disease. Treatment: low tidal volume ventilation (6 mL/kg IBW — avoids ventilator-induced lung injury by preventing alveolar overdistension), PEEP (keeps alveoli open at end-expiration, prevents cyclic recruitment/derecruitment injury), prone positioning (12–16 hours/day redistributes perfusion to better-ventilated lung regions → improves V/Q matching → improves oxygenation), conservative fluid strategy (minimize pulmonary edema once resuscitated).
Virchow's triad: venous stasis (immobility, prolonged travel, heart failure, venous insufficiency) + hypercoagulability (malignancy, pregnancy, oral contraceptives, hereditary thrombophilia — Factor V Leiden most common) + endothelial injury (surgery, trauma, central venous catheter) → deep vein thrombosis → thromboembolism to pulmonary circulation. Pathophysiology: thrombus lodges in pulmonary artery → mechanical obstruction → increases pulmonary vascular resistance → V/Q mismatch (ventilation continues past occluded vessels but no perfusion → wasted ventilation — anatomical dead space increases) → hypoxemia. Also: hypoxemia → reflex bronchoconstriction + platelet release of serotonin/thromboxane → further pulmonary vasoconstriction. Large PE: massive increase in pulmonary artery pressure → acute RV pressure overload → RV dilation → interventricular septum shifts left → impairs LV filling → ↓CO → obstructive shock. ABG: MOST COMMON finding in PE is respiratory alkalosis (hyperventilation from hypoxia and chest pain). Classic triad (pleuritic chest pain + dyspnea + hemoptysis) present in only 20%. Wells score for clinical probability + D-dimer (sensitive, not specific). Definitive: CT pulmonary angiography (CTPA). Treatment: anticoagulation (heparin initially, then warfarin or DOAC). Massive PE: systemic thrombolytics (tPA) if hemodynamic instability. Surgical or catheter-directed embolectomy for refractory cases.
COPD Oxygen Therapy: Why Target 88–92%?
In most patients, the primary respiratory drive is hypercapnia — rising CO₂ stimulates the central chemoreceptors in the medulla. However, patients with severe chronic COPD chronically retain CO₂. Their central chemoreceptors become desensitized to high CO₂ over time. Their respiratory drive shifts to rely primarily on hypoxia — the peripheral chemoreceptors in the carotid bodies sense low PaO₂. This is the hypoxic respiratory drive. If you give these patients high-flow oxygen (SpO₂ >95%), you eliminate the hypoxic drive, and they hypoventilate further — CO₂ rises, pH falls. The target SpO₂ for COPD patients with known or suspected CO₂ retention is 88–92%, not the standard 94–98%. This is not withholding oxygen — it is titrating oxygen to avoid precipitating hypercapnic respiratory failure. Use nasal cannula at 1–2 L/min or a Venturi mask set at 24–28% FiO₂.
Nursing Assessment Priority: Respiratory System Evaluation
Respiratory assessment integrates what you see, hear, and measure. Inspection: respiratory rate (most sensitive early sign — tachypnea >20 is significant), use of accessory muscles (scalene, sternocleidomastoid engagement means the patient is working hard to breathe), pursed-lip breathing (COPD patients naturally do this — creates intrinsic PEEP to prevent alveolar collapse during exhalation), tripod positioning (sitting upright, leaning forward, hands on knees — maximizes diaphragm excursion). Auscultation: crackles (fluid in airways — pneumonia, heart failure), wheezes (narrowed airways — asthma, COPD), stridor (upper airway obstruction — croup, epiglottitis, foreign body — EMERGENCY), absent breath sounds (atelectasis, pneumothorax, large pleural effusion). Measurement: SpO₂ (target 94–98% general, 88–92% COPD), capnography (ETCO₂) in intubated patients. An ETCO₂ suddenly dropping to near zero means no gas exchange — cardiac arrest, displaced tube, or massive PE.
AKI, CKD, and glomerular disease — from oliguria to uremia
The kidneys perform functions that no other organ can replicate: excreting nitrogen waste, regulating electrolytes and acid-base balance, activating vitamin D, producing erythropoietin, and controlling blood pressure via renin. When they fail — acutely or chronically — every other organ system suffers. Understanding the three AKI categories and the CKD consequence cascade is essential bedside knowledge.
Mechanism: decreased renal blood flow → decreased GFR → oliguria. The tubular cells are normal and functioning: they aggressively retain Na⁺ and water (compensating for perceived hypovolemia). Causes: true hypovolemia (hemorrhage, dehydration, burns, GI losses), decreased cardiac output (cardiogenic shock, severe HF), vasodilation (septic shock, distributive shock), renal artery stenosis, drugs that reduce glomerular perfusion pressure (NSAIDs block afferent arteriolar prostaglandin-mediated dilation; ACE inhibitors/ARBs block efferent arteriolar angiotensin-mediated constriction → both reduce GFR). Diagnostic clues: BUN:Cr ratio >20:1 (kidneys retain urea — normal ratio 10–20:1), FENa (fractional excretion of Na) <1% (kidneys avidly retain Na), urine Na <20 mEq/L, urine osmolality >500 mOsm/kg (concentrated urine), urine specific gravity >1.020, bland urinalysis (no casts). Management: restore perfusion — IV fluids if hypovolemic, optimize cardiac output in cardiogenic states. Pre-renal AKI is REVERSIBLE if perfusion is restored before tubular ischemia occurs (within hours).
Causes direct injury to the nephron itself. Most common: acute tubular necrosis (ATN). Two mechanisms: (1) Ischemic ATN: prolonged pre-renal state → tubular cells become ischemic → necrosis of proximal tubule and thick ascending limb (most metabolically active, most O₂-dependent segments). The transition from pre-renal to ATN is time-dependent — the longer hypoperfusion lasts, the more likely irreversible tubular damage occurs. (2) Nephrotoxic ATN: aminoglycosides concentrate in proximal tubular cells via megalin receptor → mitochondrial toxicity → cell death. Contrast dye → direct tubular toxicity + vasoconstriction. Myoglobin (rhabdomyolysis) → tubular obstruction + direct oxidative injury → myoglobinuria (tea-colored urine). Cisplatin, amphotericin B, vancomycin (with nephrotoxic drugs). Diagnostic clues: BUN:Cr ratio <20:1 (tubules cannot concentrate or retain urea), FENa >2% (tubules cannot retain Na — damaged), urine osmolality <350 mOsm/kg (isosthenuria — unable to concentrate), MUDDY BROWN GRANULAR CASTS on urinalysis (hallmark of ATN — tubular cell debris), urine Na >40 mEq/L. Management: remove nephrotoxin, support hemodynamics, AVOID further nephrotoxins, careful fluid management, electrolyte management (hyperkalemia, acidosis). ATN recovery: oliguria phase (days to weeks) → polyuric phase (tubules repaired but not yet able to concentrate — can lose large amounts of fluid/electrolytes — monitor carefully) → recovery phase.
Mechanism: bilateral obstruction (or unilateral if solitary kidney) → back-pressure transmitted to Bowman's capsule → opposes glomerular filtration → GFR falls. Causes: benign prostatic hyperplasia (BPH — most common cause in elderly men; presents with urinary hesitancy, weak stream, nocturia, followed by acute retention → postrenal AKI), nephrolithiasis (bilateral stones or large stone in solitary kidney), bladder or prostate cancer, retroperitoneal fibrosis, bilateral ureteral ligation during gynecologic surgery, cervical cancer, Foley catheter malposition or obstruction. Diagnostic clues: hydronephrosis on renal ultrasound (FIRST test to order — bedside available, no contrast needed), variable BUN:Cr ratio, variable FENa (early = low like pre-renal; prolonged = high like ATN as back-pressure damages tubules). Management: relieve obstruction — if bladder outlet obstruction, insert Foley catheter. If ureteral obstruction, nephrostomy tube or ureteral stent. Post-obstructive diuresis: after relieving obstruction of >24–48h duration, expect massive diuresis (kidneys excrete accumulated solutes and water) — replace fluid mL-for-mL to prevent dangerous dehydration.
CKD Consequences — A Cascade of Organ Dysfunction
Uremia
Nitrogen waste (BUN, creatinine, indoles, guanidines, uric acid) accumulates. Uremic pruritus (itching), uremic encephalopathy (asterixis — flapping tremor, confusion, seizures), uremic pericarditis (friction rub), uremic platelet dysfunction (prolonged bleeding time despite normal platelet count — use DDAVP before procedures).
Electrolyte & Acid-Base
Hyperkalemia (kidneys fail to excrete K⁺ — life-threatening arrhythmia risk). Metabolic acidosis (kidneys fail to excrete H⁺ and regenerate HCO₃⁻ — chronic acidosis accelerates bone disease and muscle catabolism). Hyperphosphatemia (retain phosphate → binds calcium → hypocalcemia + secondary hyperparathyroidism → renal osteodystrophy). Hypermagnesemia.
Anemia of CKD
Damaged interstitial cells (peritubular fibroblasts) of the failing kidney produce insufficient erythropoietin (EPO). EPO deficiency → decreased RBC production → normocytic normochromic anemia. Also: iron deficiency (poor GI absorption, inflammation), shortened RBC survival. Treatment: erythropoiesis-stimulating agents (ESA — epoetin alfa, darbepoetin) + iron supplementation. Target Hgb 10–11.5 g/dL in CKD (higher targets increase stroke and cardiovascular events).
Renal Osteodystrophy
Damaged kidney cannot convert 25-hydroxyvitamin D → 1,25-dihydroxyvitamin D (calcitriol) (1-alpha-hydroxylase is in the kidney) → ↓calcium absorption → hypocalcemia → secondary hyperparathyroidism (PTH rises to mobilize bone calcium) → bone resorption → osteitis fibrosa cystica. Combined with phosphate retention → vascular calcification. Treatment: active vitamin D (calcitriol or paricalcitol), phosphate binders (calcium carbonate, sevelamer, lanthanum).
Nephrotoxic Medications Requiring Dose Adjustment or Avoidance in CKD
The kidneys filter and excrete most drugs and their metabolites. As GFR declines, renally cleared drugs accumulate to toxic levels unless doses are adjusted. Critical drugs requiring dose reduction or avoidance in CKD: (1) Aminoglycosides (gentamicin, tobramycin) — concentrate in proximal tubular cells, causing ATN; require dose adjustment and trough monitoring. (2) NSAIDs — inhibit prostaglandin-mediated afferent arteriolar dilation → reduce GFR acutely; worsen CKD progression with chronic use. (3) Contrast dye — iodinated contrast causes contrast-induced nephropathy (CIN) by direct tubular toxicity and renal vasoconstriction; pre-hydrate with IV saline, hold metformin. (4) Metformin — renally cleared; accumulates in CKD → lactic acidosis (metformin inhibits mitochondrial complex I → increases anaerobic lactate production); hold if eGFR <30. (5) Potassium-sparing diuretics, ACE inhibitors, ARBs — increase hyperkalemia risk in CKD.
Nursing Assessment Priority: Renal Function Monitoring
Urine output is the most accessible real-time indicator of renal perfusion and function. Normal adult urine output is 0.5–1 mL/kg/hour (30–60 mL/hour for a 60 kg patient). Oliguria <0.5 mL/kg/hr persisting >6 hours is the KDIGO criterion for AKI Stage 1. Anuria (<100 mL/24h) suggests complete obstruction or severe AKI. Assess: Is this pre-renal (hypovolemia → give fluids and reassess), intrinsic (ATN → avoid nephrotoxins, manage electrolytes), or post-renal (obstruction → bladder scan first — if >300 mL, place Foley; if Foley already in place and no output, flush to check patency)? Monitor: daily creatinine and BUN trends, potassium (hyperkalemia is the most immediately life-threatening complication of AKI), magnesium, phosphorus. Weigh daily. In CKD patients on HD, know their dry weight and interdialytic fluid gains.
A patient post-cardiac surgery is oliguric (urine output 15 mL/hr). BUN is 42, creatinine is 1.8. BUN:Cr ratio is 23:1. FENa is 0.4%. Urine osmolality is 580 mOsm/kg. What is the most likely AKI category?
A myocardial infarction patient's troponin is normal 2 hours after symptom onset. What is the correct interpretation?
